ATLASVanEck Biotech ETF (BBH): outlook, holdings and fees
VanEck Biotech ETF (BBH) is an exchange-traded fund and is managed by VanEck. The expense ratio is 0.33% and the yield is 0.40%. The ten largest holdings are 74% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on BBH
| Last price | $256.87 (-0.4%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 52% |
| Likely 1-month range (50%) | $247.71 – $268.29 |
| Normal 1-day range (±1σ) | ±1.4% |
| Distribution yield | 0.40% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
BBH fund facts
| Issuer | VanEck |
|---|---|
| Theme | Biotech |
| Assets under management | $482M |
| Expense ratio | 0.33% |
| Number of holdings | 25 |
| Portfolio turnover | 18% |
| Inception | Dec 20, 2011 |
| Exchange | NASDAQ |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
BBH top holdings
| Holding | Sector | Weight |
|---|---|---|
| Amgen Inc AMGN | Healthcare | 16.18% |
| Gilead Sciences Inc GILD | Healthcare | 13.59% |
| Vertex Pharmaceuticals Inc VRTX | Healthcare | 8.44% |
| Moderna Inc MRNA | Healthcare | 7.05% |
| Regeneron Pharmaceuticals Inc REGN | Healthcare | 6.68% |
| Natera Inc NTRA | Healthcare | 5.12% |
| IQVIA Holdings Inc IQV | Healthcare | 4.58% |
| Illumina Inc ILMN | Healthcare | 4.31% |
| argenx NV ADR ARGX | Healthcare | 3.98% |
| Revolution Medicines Inc RVMD | Healthcare | 3.78% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
BBH sector breakdown
| Sector | Weight |
|---|---|
| Healthcare | 100.0% |
By region: North America 100.0%.
BBH returns and risk
| Year to date | +25.5% |
|---|---|
| 1 year | +39.4% |
| 3 years (annualised) | +16.6% |
| 5 years (annualised) | +5.2% |
| 10 years (annualised) | +8.4% |
| Volatility (3 years) | 17.4% |
| Sharpe ratio (3 years) | 0.71 |
Past returns do not guarantee future results.
BBH: frequently asked questions
What does BBH invest in?
VanEck Biotech ETF invests in a portfolio of securities. Its largest holdings are Amgen Inc (16.2%), Gilead Sciences Inc (13.6%), Vertex Pharmaceuticals Inc (8.4%), Moderna Inc (7.0%), Regeneron Pharmaceuticals Inc (6.7%).
What is the BBH expense ratio?
0.33% a year: about $33.00 for every $10,000 invested.
What is the BBH dividend yield?
0.40%. ATLAS does not hold the exact distribution dates for ETFs.
Will BBH go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 52%, with a likely range (50%) of $247.71 to $268.29 from $256.87 today. It is a probability, not a prediction.
How has BBH performed?
Year to date +25.5%, one year +39.4%, three years +16.6% a year, five years +5.2% a year. Past returns do not guarantee future results.
Similar ETFs: Biotech
Educational information, not investment advice. Disclaimer